These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
902 related articles for article (PubMed ID: 30769127)
1. Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats. Mirza R; Sharma B Brain Res Bull; 2019 Apr; 147():36-46. PubMed ID: 30769127 [TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of pioglitazone, a selective peroxisome proliferator-activated receptor-γ agonist in prenatal valproic acid-induced behavioral and biochemical autistic like features in Wistar rats. Mirza R; Sharma B Int J Dev Neurosci; 2019 Aug; 76():6-16. PubMed ID: 31128204 [TBL] [Abstract][Full Text] [Related]
3. Selective modulator of peroxisome proliferator-activated receptor-α protects propionic acid induced autism-like phenotypes in rats. Mirza R; Sharma B Life Sci; 2018 Dec; 214():106-117. PubMed ID: 30366038 [TBL] [Abstract][Full Text] [Related]
4. The neuroprotective effect of Diosgenin in the rat Valproic acid model of autism. Reza Naghdi M; Ahadi R; Motamed Nezhad A; Sadat Ahmadi Tabatabaei F; Soleimani M; Hajisoltani R Brain Res; 2024 Sep; 1838():148963. PubMed ID: 38705555 [TBL] [Abstract][Full Text] [Related]
5. A selective peroxisome proliferator-activated receptor-γ agonist benefited propionic acid induced autism-like behavioral phenotypes in rats by attenuation of neuroinflammation and oxidative stress. Mirza R; Sharma B Chem Biol Interact; 2019 Sep; 311():108758. PubMed ID: 31348919 [TBL] [Abstract][Full Text] [Related]
6. Benefits of agomelatine in behavioral, neurochemical and blood brain barrier alterations in prenatal valproic acid induced autism spectrum disorder. Kumar H; Sharma BM; Sharma B Neurochem Int; 2015 Dec; 91():34-45. PubMed ID: 26498253 [TBL] [Abstract][Full Text] [Related]
7. Cilostazol attenuated prenatal valproic acid-induced behavioural and biochemical deficits in a rat model of autism spectrum disorder. Luhach K; Kulkarni GT; Singh VP; Sharma B J Pharm Pharmacol; 2021 Oct; 73(11):1460-1469. PubMed ID: 34459916 [TBL] [Abstract][Full Text] [Related]
8. Memantine ameliorates autistic behavior, biochemistry & blood brain barrier impairments in rats. Kumar H; Sharma B Brain Res Bull; 2016 Jun; 124():27-39. PubMed ID: 27034117 [TBL] [Abstract][Full Text] [Related]
9. The histamine H3R antagonist DL77 attenuates autistic behaviors in a prenatal valproic acid-induced mouse model of autism. Eissa N; Jayaprakash P; Azimullah S; Ojha SK; Al-Houqani M; Jalal FY; Łażewska D; Kieć-Kononowicz K; Sadek B Sci Rep; 2018 Aug; 8(1):13077. PubMed ID: 30166610 [TBL] [Abstract][Full Text] [Related]
10. Ameliorating effect of pioglitazone on prenatal valproic acid-induced behavioral and neurobiological abnormalities in autism spectrum disorder in rats. Sandhu A; Rawat K; Gautam V; Bhatia A; Grover S; Saini L; Saha L Pharmacol Biochem Behav; 2024 Apr; 237():173721. PubMed ID: 38307465 [TBL] [Abstract][Full Text] [Related]
11. Assessment of behavioral, morphological and electrophysiological changes in prenatal and postnatal valproate induced rat models of autism spectrum disorder. Fereshetyan K; Chavushyan V; Danielyan M; Yenkoyan K Sci Rep; 2021 Dec; 11(1):23471. PubMed ID: 34873263 [TBL] [Abstract][Full Text] [Related]
13. Validation of prenatal versus postnatal valproic acid rat models of autism: A behavioral and neurobiological study. Elnahas EM; Abuelezz SA; Mohamad MI; Nabil MM; Abdelraouf SM; Bahaa N; Hassan GA; Ibrahim EA; Ahmed AI; Aboul-Fotouh S Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110185. PubMed ID: 33238165 [TBL] [Abstract][Full Text] [Related]
14. Targeting PPARα in the rat valproic acid model of autism: focus on social motivational impairment and sex-related differences. Scheggi S; Guzzi F; Braccagni G; De Montis MG; Parenti M; Gambarana C Mol Autism; 2020 Jul; 11(1):62. PubMed ID: 32718349 [TBL] [Abstract][Full Text] [Related]
15. Phosphodiesterase inhibitor, ibudilast alleviates core behavioral and biochemical deficits in the prenatal valproic acid exposure model of autism spectrum disorder. Sandhu A; Rawat K; Gautam V; Sharma A; Kumar A; Saha L Brain Res; 2023 Sep; 1815():148443. PubMed ID: 37290608 [TBL] [Abstract][Full Text] [Related]
16. Prenatal Exposure to Valproic Acid Affects Microglia and Synaptic Ultrastructure in a Brain-Region-Specific Manner in Young-Adult Male Rats: Relevance to Autism Spectrum Disorders. Gąssowska-Dobrowolska M; Cieślik M; Czapski GA; Jęśko H; Frontczak-Baniewicz M; Gewartowska M; Dominiak A; Polowy R; Filipkowski RK; Babiec L; Adamczyk A Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443651 [TBL] [Abstract][Full Text] [Related]
17. Vitamin A ameliorates valproic acid-induced autism-like symptoms in developing zebrafish larvae by attenuating oxidative stress and apoptosis. Wang J; Zou L; Jiang P; Yao M; Xu Q; Hong Q; Zhu J; Chi X Neurotoxicology; 2024 Mar; 101():93-101. PubMed ID: 38191030 [TBL] [Abstract][Full Text] [Related]
18. The effect of ketogenic diet in an animal model of autism induced by prenatal exposure to valproic acid. Castro K; Baronio D; Perry IS; Riesgo RDS; Gottfried C Nutr Neurosci; 2017 Jul; 20(6):343-350. PubMed ID: 26856821 [TBL] [Abstract][Full Text] [Related]
19. Vitamin A supplementation ameliorates prenatal valproic acid-induced autism-like behaviors in rats. Liu Z; Wang J; Xu Q; Wu Z; You L; Hong Q; Zhu J; Chi X Neurotoxicology; 2022 Jul; 91():155-165. PubMed ID: 35594946 [TBL] [Abstract][Full Text] [Related]
20. Vinpocetine amended prenatal valproic acid induced features of ASD possibly by altering markers of neuronal function, inflammation, and oxidative stress. Luhach K; Kulkarni GT; Singh VP; Sharma B Autism Res; 2021 Nov; 14(11):2270-2286. PubMed ID: 34415116 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]